|
Institute of Medicine
36th Annual Meeting
The National Academy of Sciences Building--2100 C Street, N.W.
Monday, October 9, 2006
Stem Cells and Tissue Engineering: Science and Public Policy
Regenerative Medicine
9:20 a.m.
Introduction of the Program
Helen M. Blau, Ph.D., Director, Baxter Laboratory in Genetic Pharmacology, Stanford University School of Medicine
9:35 a.m.
Stem Cell Research Enterprise: Key Issues in Science and Public Policy
Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean, Albert Einstein College of Medicine
9:55 a.m.
Questions and Discussion
10:05 a.m.
Science to Clinic: Near Term
Robert S. Negrin, M.D., Professor of Medicine and Division Chief, Blood and Marrow Transplant Program, Stanford University
Robert S. Langer, Sc.D., Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology
George Q. Daley, M.D., Ph.D., Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Associate Professor of Pediatrics, Children's Hospital Boston
10:50 a.m.
Questions and Discussion
11:35 a.m.
Ethical Considerations
R. Alta Charo, J.D., Warren P. Knowles Professor of Law and Bioethics, University of Wisconsin School of Law
11:50 a.m.
Questions and Discussion
12:00 p.m.
International Perspective
Anne McLaren, DBE, DPhil., FRS, Principal Research Associate, The Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge University
12:20 p.m.
Questions and Discussion
2:00 p.m.
Introduction of Afternoon Program
Cato T. Laurencin, M.D., Ph.D., Lillian T. Pratt Distinguished Professor, Chairman of Orthopedic Surgery, and Professor of Biomedical and Chemical Engineering, University of Virginia Health System
2:10 p.m.
Science of Tomorrow
Jeffrey A. Hubbell, Ph.D., Professor, Swiss Federal Institute of Technology Lausanne
David T. Scadden, M.D., Professor of Medicine, Harvard Medical School; Director, Center for Regenerative Medicine, Massachusetts General Hospital and Co-Director, Harvard Stem Cell Institute
Irving L. Weissman, M.D., Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University
2:55 p.m.
Questions and Discussion
Institutional and Policy Questions
3:10 p.m.
Building Scientific Enterprise: Critical Issues
Zach W. Hall, Ph.D., President, California Institute for Regenerative Medicine
Edward E. Penhoet, Ph.D., President, Gordon and Betty Moore Foundation
3:50 p.m.
Questions and Discussion
4:05 p.m.
Science and Public Policy: Strategies for Alignment
Conversation with Panel and Audience
Paul Grant Rogers, J.D., Partner, Hogan & Hartson, LLP
Donna E. Shalala, Ph.D., President, University of Miami
Susan L. Solomon, J.D., Chief Executive Officer, New York Stem Cell Foundation
4:50 p.m.
Introduction of the Class of 2006 IOM Members, 2006-2007 Robert Wood Johnson Health Policy Fellows and Senior Nurse Scholar-In-Residence
Harvey V. Fineberg, M.D., Ph.D., President, Institute Of Medicine
Presentation of The Gustav O. Lienhard Award
Fitzhugh Mullan, M.D., Murdock Head Professor of Medicine and Health Policy, George Washington University School of Public Health and Health Services
Adjourn
Online presentations from the Annual Meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read in the National Academies Legal Statement.
Annual Meeting Program Planning Committee
Helen M. Blau, Ph.D., Director, Baxter Laboratory in Genetic Pharmacology, Stanford University School of Medicine
Zach W. Hall, Ph.D., President, California Institute for Regenerative Medicine
Cato T. Laurencin, M.D., Ph.D., Lillian T. Pratt Distinguished Professor, Chairman of Orthopedic Surgery and Professor of Biomedical and Chemical Engineering, University of Virginia Health System
Susanne A. Stoiber, M.P.A., M.Sc., Executive Officer, Institute of Medicine
|